These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 23923395)

  • 1. Effect of water soluble carrier on dissolution profiles of diclofenac sodium.
    Cwiertnia B
    Acta Pol Pharm; 2013; 70(4):721-6. PubMed ID: 23923395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
    Zahedi P; Lee PI
    Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solubility of selected derivatives of 1,4-benzodiazepin-2-one in solid dispersions in PEG 6000.
    Cwiertnia B
    Acta Pol Pharm; 2006; 63(2):135-9. PubMed ID: 17514877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
    Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
    Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicochemical characterisation, drug polymer dissolution and in vitro evaluation of phenacetin and phenylbutazone solid dispersions with polyethylene glycol 8000.
    Khan S; Batchelor H; Hanson P; Perrie Y; Mohammed AR
    J Pharm Sci; 2011 Oct; 100(10):4281-94. PubMed ID: 21560130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.
    Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A
    Colloids Surf B Biointerfaces; 2010 Mar; 76(1):170-8. PubMed ID: 19945828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation, characterization and dissolution studies of fast release diclofenac sodium tablets from PVP solid dispersions.
    Lamas MC; Leonardi D; Lambri OA; Bassani G; Barrera MG; Bolmaro RE; Salomon CJ
    Pharm Dev Technol; 2010; 15(2):162-8. PubMed ID: 19589124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diclofenac salts, II. Solid dispersions in PEG6000 and Gelucire 50/13.
    Fini A; Moyano JR; Ginés JM; Perez-Martinez JI; Rabasco AM
    Eur J Pharm Biopharm; 2005 May; 60(1):99-111. PubMed ID: 15848062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical principles of controlled release solid dispersion containing a poorly water-soluble drug.
    Tran TT; Tran PH; Lim J; Park JB; Choi SK; Lee BJ
    Ther Deliv; 2010 Jul; 1(1):51-62. PubMed ID: 22816119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation, characterization and tableting of cilnidipine solid dispersions.
    Hu L; Song W; Niu F; Jiao K; Jia Z
    Pak J Pharm Sci; 2013 May; 26(3):629-36. PubMed ID: 23625441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
    Patil MP; Gaikwad NJ
    Acta Pharm; 2009 Mar; 59(1):57-65. PubMed ID: 19304558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of prednisone:polyethylene glycol 6000 fast-release tablets from solid dispersions: solid-state characterization, dissolution behavior, and formulation parameters.
    Leonardi D; Barrera MG; Lamas MC; Salomón CJ
    AAPS PharmSciTech; 2007 Dec; 8(4):E108. PubMed ID: 18181529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dissolution enhancement of piroxicam in its physical mixtures and solid dispersion formulations using gluconolactone and glucosamine hydrochloride as potential carriers.
    Al-Hamidi H; Obeidat WM; Nokhodchi A
    Pharm Dev Technol; 2015 Jan; 20(1):74-83. PubMed ID: 24392858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes.
    Yan YD; Sung JH; Kim KK; Kim DW; Kim JO; Lee BJ; Yong CS; Choi HG
    Int J Pharm; 2012 Jan; 422(1-2):202-10. PubMed ID: 22085435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the solubility of ampelopsin by solid dispersions and inclusion complexes.
    Ruan LP; Yu BY; Fu GM; Zhu DN
    J Pharm Biomed Anal; 2005 Jul; 38(3):457-64. PubMed ID: 15925247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissolution rate of furosemide from polyethylene glycol solid dispersions.
    Ozdemir N; Ordu S
    Farmaco; 1997 Oct; 52(10):625-9. PubMed ID: 9507675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation, characterization, and dissolution studies of ibuprofen solid dispersions using polyethylene glycol (PEG), talc, and PEG-talc as dispersion carriers.
    Khan GM; Jiabi Z
    Drug Dev Ind Pharm; 1998 May; 24(5):455-62. PubMed ID: 9876608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of rofecoxib-polyethylene glycol 4000 solid dispersions and tablets based on solid dispersions.
    Liu C; Desai KG
    Pharm Dev Technol; 2005; 10(4):467-77. PubMed ID: 16370176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
    Prabhu S; Ortega M; Ma C
    Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of water uptake, gel network, and disintegration time on prednisone release from encapsulated solid dispersions.
    Leonardi D; Salomon CJ
    Pharm Dev Technol; 2010; 15(2):184-91. PubMed ID: 19621984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.